Incyte Announces Positive CHMP Opinion for Zynyz® in First-Line Advanced Anal Canal Cancer
Incyte Receives Positive CHMP Recommendation for Zynyz® (retifanlimab) as First-Line Therapy in Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC) Incyte today announced that the Committee for Medicinal Products…
Finerenone Recommended in the EU for Treating Heart Failure Patients with LVEF ≥40%
Finerenone Recommended in the EU for Heart Failure Patients with LVEF ≥40% Bayer today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…
AstraZeneca Expands Weight Management Portfolio via Collaboration with CSPC Pharmaceuticals
AstraZeneca Expands Weight Management Portfolio via Collaboration with CSPC Pharmaceuticals AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with CSPC Pharmaceuticals to advance the development of…
CHMP Grants Positive Opinion for AKEEGA® in BRCA1/2-Mutated mHSPC
Johnson & Johnson Secures CHMP Positive Opinion for AKEEGA®—a Dual-Action Tablet Combining Niraparib and Abiraterone Acetate—for Treating Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in Patients with BRCA1/2 Mutations Johnson & Johnson today…
Lilly Chooses Pennsylvania for New Injectable Medicine and Device Manufacturing Facility
Lilly Establishes New Injectable Medicine and Device ManufacturingLilly Chooses Pennsylvania for New Injectable Medicine and Device Manufacturing Facility Eli Lilly and Company today announced plans to invest more than $3.5 billion in…
Glaukos Announces FDA Approval of NDA Supplement Permitting Re-Administration of iDose® TR
Glaukos Announces FDA Approval for Re-Administration of iDose® TR Glaukos Corporation, an ophthalmic pharmaceutical and medical technology focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal…
WuXi Biologics and Sinorda Biomedicine Forge Strategic Alliance to Advance Bispecific Antibody Development and Manufacturing
WuXi Biologics and Sinorda Biomedicine Forge Strategic Partnership to Advance Development and Manufacturing of Innovative Bispecific Antibodies WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), and…
BioNTech Appoints Kylie Jimenez as Chief People Officer to Management Board
BioNTech Appoints Kylie Jimenez as Chief People Officer to Management Board BioNTech SE announced today that the Supervisory Board has appointed Kylie Jimenez to the Management Board as Chief People Officer…
Litifilimab Earns FDA Breakthrough Designation for Cutaneous Lupus—First Targeted Therapy Hope
Biogen’s Litifilimab Earns FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus—First Targeted Therapy on the Horizon Biogen Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough…
RCEM’s new film promotes a specialty to be proud of | AnnualConference 2026
This is the place for emergency medicine’ features real people working in emergency departments in Coventry and Manchester. Commissioned by the Royal College of Emergency Medicine (RCEM), the film is…
Intellia Therapeutics Announces FDA Lifts Clinical Hold on MAGNITUDE-2 Phase 3 Trial for ATTRv-PN
Intellia Therapeutics Announces FDA Lifts Clinical Hold on MAGNITUDE-2 Phase 3 Trial for ATTRv-PN Intellia Therapeutics, Inc., a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies,…
ICON’s Accellacare Site Network Enhances Oncology Research Capabilities Through New Cancer Institute Partnership
ICON’s Accellacare Site Network Enhances Oncology Research Through New Cancer Institute Partnership ICON plc today announced a significant expansion of oncology research capabilities within its Accellacare Site Network through the…